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Transcriptomic analysis of peritoneal cells in a
mouse model of sepsis: confirmatory and novel
results in early and late sepsis
Minny Bhatty1, Ruping Fan2, William M Muir3, Stephen B Pruett1,2*† and Bindu Nanduri1†
Abstract
Background: The events leading to sepsis start with an invasive infection of a primary organ of the body followed
by an overwhelming systemic response. Intra-abdominal infections are the second most common cause of sepsis.
Peritoneal fluid is the primary site of infection in these cases. A microarray-based approach was used to study the
temporal changes in cells from the peritoneal cavity of septic mice and to identify potential biomarkers and
therapeutic targets for this subset of sepsis patients.
Results: We conducted microarray analysis of the peritoneal cells of mice infected with a non-pathogenic strain of
Escherichia coli. Differentially expressed genes were identified at two early (1 h, 2 h) and one late time point (18 h).
A multiplexed bead array analysis was used to confirm protein expression for several cytokines which showed
differential expression at different time points based on the microarray data. Gene Ontology based hypothesis
testing identified a positive bias of differentially expressed genes associated with cellular development and cell
death at 2 h and 18 h respectively. Most differentially expressed genes common to all 3 time points had an immune
response related function, consistent with the observation that a few bacteria are still present at 18 h.
Conclusions: Transcriptional regulators like PLAGL2, EBF1, TCF7, KLF10 and SBNO2, previously not described in
sepsis, are differentially expressed at early and late time points. Expression pattern for key biomarkers in this study is
similar to that reported in human sepsis, indicating the suitability of this model for future studies of sepsis, and the
observed differences in gene expression suggest species differences or differences in the response of blood
leukocytes and peritoneal leukocytes.
Keywords: Intra-abdominal sepsis, Microarray, Peritoneal leukocytes
Background
The hallmark of sepsis is a systemic overwhelming
inflammatory response induced by an infectious agent.
Despite extensive research, sepsis still remains a lead-
ing cause of death in the United States [1]. Multiple
immunological molecules and pathways with redundant
roles contribute to the outcome of sepsis. Microarray
based transcription profiling for understanding the patho-
physiology of sepsis has predominantly focused on the
blood profiles from sepsis patients or animal models
[2-4], with few reports on the primary organs in which
the infection originated, such as lung [5] and brain [4].
Sepsis caused by intra-abdominal infections arising
from a ruptured appendix, penetrating trauma and peri-
tonitis accounts for about 20% of all sepsis cases [6], with
a mortality rate of 25-35% [7]. Although sepsis is a sys-
temic infection, studies indicate that the inflammatory
response is variegated amongst different organs and
peripheral blood [8-10]. This variation can be attributed
to the nature of the insult or infection, and the cellular
composition and the microenvironment of each organ
system [11]. Several different studies have provided evi-
dence of differential expression of cytokines and chemo-
kines in different organs or blood in animal models of
sepsis [9-13]. A study in a mouse endotoxemia model
* Correspondence: pruett@cvm.msstate.edu
†Equal contributors
1Department of Basic Sciences, College of Veterinary Medicine, Mississippi
State University, Mississippi State, MS 39762, USA
2Department of Cellular Biology and Anatomy, Louisiana State University
Health Sciences Center, Shreveport, LA 71130, USA
Full list of author information is available at the end of the article
© 2012 Bhatty et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Bhatty et al. BMC Genomics 2012, 13:509
http://www.biomedcentral.com/1471-2164/13/509
showed that the mRNA levels of IL-1β, TNF-α and MIP-2
are significantly different in neutrophils derived from
lungs as compared to those from peripheral blood [12].
Similar differences in IL-1β levels in lung and blood have
been reported in immunohistochemistry studies [13].
Organ specific expression of CXC chemokines (MIP-2
and KC) and a CC chemokine (RANTES) has been
shown in a mouse model of peritonitis and endotoxemia
[9,10]. In addition to differences in the cytokine and che-
mokine expression, there is evidence that the signaling
and the receptors leading to the inflammatory response
also vary depending upon the anatomical location of the
leukocytes involved. This is exemplified by a study that
showed that LPS induced NF-κB activation in liver is
mediated through TNF-α and IL-1 receptor dependent
pathways while in the lungs it is largely independent of
these receptors[14]. Tolerance to endotoxin in a mouse
model has also been shown to be compartmentalized
depending upon the cell type in a given organ [14].
Therefore, it is important to evaluate the inflammatory
responses at the primary focus of the infection which
leads to sepsis in order to understand the progression of
sepsis from the primary location of infection to a severe
systemic condition and then to resolution, as the inducing
microbes are cleared.
To date, genome wide transcriptional changes in cells
isolated from the peritoneal fluid, the primary site of in-
fection in intra-abdominal sepsis have not been reported.
Here, using microarrays, we describe temporal (early and
late) changes in inflammatory responses in cells from the
peritoneal fluid of mice infected with a non-pathogenic
strain of Escherichia coli. The mouse model used in this
study involves the intraperitoneal administration of a
non-pathogenic strain of E. coli. This is designed to rep-
resent the patient population in which sepsis is caused by
microbial contamination of the peritoneal cavity due to
conditions that compromise the normal mucosal barrier.
The infections often start as polymicrobial but in more
than half of the cases, E. coli is typically the only type of
bacterium isolated [15,16]. This model of sepsis causes
time-dependent changes that are consistent within treat-
ment groups [17,18], whereas cecal ligation puncture and
the fecal pellet models exhibit considerable variation
within groups at early time points and thus are not well
suited for assessment of time dependent changes [17,18].
Results
Animal model, bacterial and differential cell counts in
peritoneal fluid
The mouse model of intra-abdominal sepsis used here is
based on our previous study [19], which indicates that
18 h is about the latest time point for sampling, without
the risk of animal mortality or morbidity. Levels of pro-
inflammatory cytokines (TNF-α, IFN-γ and GM-CSF)
are elevated as early as 1 h while most other cytokines
peak within 2 h of infection [19,20]. Therefore, we chose
two early (1 h, 2 h) and one late (18 h) time point in
this study. The peritoneal fluid bacterial counts were
highest at 2 h (Figure 1A), consistent with our previous
findings [19]. By 18 h most of the bacteria were cleared
(Figure 1A), which should allow the resolution of inflam-
mation. The survival study also indicates that most of the
mice survive at this dose of infection (Additional file 1:
Figure S1). At 1 h and 2 h > 85% of the cells in the peri-
toneal fluid are macrophages (Figure 1B), and at 18 h
they are predominantly neutrophils (~80%) (Figure 1C).
The percentage of macrophages that contain 3 or more
E. coli cells increases at 2 h as compared to 1 h indicating
increased uptake of bacteria. Thus, the changes in gene
expression noted in this study between early and late
time points undoubtedly reflect both changes in gene
expression and changes in the predominant cell type.
However, this change in cell types represents the natural
response to sepsis and the beginning of the process of
resolution and the results reflect overall gene expression
in peritoneal cells during this time period. Therefore,
we believe that these results are useful, even though it
cannot be determined with certainty which type(s) of
cells express the genes detected.
Microarray analysis
We used the Affymetrix 430 2.0 mouse microarray plat-
form to evaluate the early (1 h, 2 h) and late (18 h)
changes in the transcriptional profiles of peritoneal cells
from E. coli infected and control mice. The distribution
of the 5244 differentially expressed (DE) genes shared
among the different time points and those unique to each
time point are shown as a Venn diagram in Figure 2.
A majority of the DE genes were unique to 18 h, while
most of the DE genes at 1 h were shared with other time
points, although in some cases the direction of change
is different.
Analysis of gene expression at early and late time points
Differences in the transcription profiles between early
and late time points, to some extent, will reflect the shift
from macrophages to neutrophils. For example, CD86, a
co-stimulatory molecule present on macrophages and
dendritic cells, implicated in early phases of the immune
response, [21,22] was significantly up-regulated at 2 h
(DE 2.73). Expression of CD177 or NB1 a neutrophil spe-
cific antigen [23] increased only at 18 h (DE 7.40). The gene
designated H2-OB is the mouse ortholog of HLA-DOB,
which forms the β chain in the MHC II molecules
expressed on macrophages, dendritic cells and B cells.
Expression of this gene was elevated at the two early time
points and significantly decreased at 18 h (Figure 3).
Expression of CR2 (complement receptor 2), PRKCA
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(protein kinase C alpha), which are expressed by macro-
phages and are important for complement activation and
neutrophil recruitment [24-26], had a similar pattern of ex-
pression (Figure 3).
To confirm that the chosen time points describe mo-
lecular events at the early and late stages in sepsis, we
looked for expression of markers specific to these stages
of sepsis. Adrenomedullin is a member of the calcitonin
peptide superfamily, and is a reliable early prognostic
marker of sepsis in humans [27,28], with a prognostic ac-
curacy similar to the APACHEII score and procalcitonin
expression [29,30]. Besides being a potent vasodilating
agent, adrenomedullin is an immune-modulating and
antibacterial mediator and a potential therapeutic target
for sepsis [31]. In abdominal sepsis, adrenomedullin sta-
bilizes the gut barrier function [32]. In our mouse model
of sepsis, adrenomedullin was significantly up-regulated
at the early time points (DE 3.95 and 5.03 at 1 and 2 h,
respectively) while it was down-regulated at 18 h
(DE −1.95) which corresponds with the recovery from
sepsis. Other cell surface markers like CD40 [33] and
CD69 [34] whose expression increases in severe sepsis
and decreases with the resolution of sepsis were signifi-
cantly up- regulated at early time points, and decreased
at 18 h (data not shown).
DE genes unique to time points
Gene expression that is unique to early or late time points
is indicative of specific host responses at these stages of
infection. The top 5 functions and canonical pathways
represented by DE genes unique to early and late time
points identified by Ingenuity pathway analysis (IPA) are
shown in Table 1. The overall effect of the increased/
decreased gene expression on the significant molecular
functions (Table 1) at 2 h and 18 h was assessed by
GOModeler [35] workflow. GOModeler enables Gene
Ontology based hypothesis-driven interrogation of high
throughput data. Since the total number of DE genes
Figure 1 Bacterial and cell counts in mouse peritoneal fluid at early and late time points. A) E. coli counts in the peritoneal fluid of control
(n = 5) and infected mice (n = 5) 1, 2 and 18 h after infection (B) Percentage of macrophages in peritoneal fluid of control (n = 9) and E. coli
infected mice (n = 5) 1, 2 and 18 h post infection (C) Percentage of neutrophils in peritoneal fluid of control (n = 5) and E. coli infected mice
(n = 5) 18 h post infection. The E. coli treated group was infected with 2 × 108 cells of E. coli intraperitoneally. The control group received
equivalent amount of PBS. The error bars indicate the standard error of mean. ***P < 0.01, *P < 0.05.
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(Figure 2) and thus the DE genes associated with each
molecular function (Table 1) at 1 h was too limited for
meaningful interpretation by GOModeler, they were
excluded from analysis. The net effect of DE at 2 h is posi-
tive for “antigen presentation”, “cellular development”,
“cellular function and maintenance”, and “cellular growth
and proliferation” (Figure 4A). Some of the top canonical
pathways at 2 h are “dendritic cell maturation”, “TREM
signaling” and “Role of JAK family kinase in IL-6 cytokine
signaling” (Table 1). Taken together these results indicate
the initiation of an inflammatory response at 2 h in re-
sponse to the bacteria. The up-regulation of genes asso-
ciated with dendritic cell maturation could indicate the
presence of maturing dendritic cells in peritoneal fluid, or
perhaps more likely, the activation of macrophages (the
predominant cell type in the peritoneal cavity at 2 h),
which express many of the same markers as dendritic cells.
A significant number of DE genes (275) uniquely
expressed at 18 h are associated with cell death. Most of
these include apoptotic genes involved in the apoptosis
of immune cells. GOModeler analysis shows a net posi-
tive bias for “cell death”. Pro- apoptotic genes like
BCL10, BCL2L11 and FAS are up-regulated at 18 h. DE
genes associated with “cell to cell signaling and inter-
action” had a net negative bias (Figure 4B). LPS mediated
MAPK signaling (Figure 5) identified at 18 h by IPA
shows that genes associated with induction of cytokine
mediated innate immune response are down-regulated
while inhibitors of NF-κB are up-regulated. The overall
pattern of gene expression at 18 h indicates an initiation
of resolution of the acute inflammatory response
observed at the early time points.
Analysis of DE genes common to all time points
DE genes (254) common to all time points were sub-
jected to hierarchical clustering and Short Time series
Expression Miner (STEM) analysis. The dendrogram
associated with the hierarchical clustering revealed that
1 h and 2 h groups were similar to each other compared
to 18 h (data not shown). STEM based significant clus-
ters show similar trends of expression (up- or down-
regulated) at the early time points.
The top functions of the DE genes common to all time
points are related to immune or inflammatory response.
Figure 3 represents the temporal trend of the transcrip-
tional changes of the immune response related genes
and the corresponding clusters which were statistically
significant in STEM analysis. A majority of these genes
code for cytokines, transcription regulators, kinases, and
transmembrane receptors. Key pro- and anti- inflamma-
tory mediators like IL-1α, MIP-1β, RANTES, CXCL-1,
IL-6 and IL-10, implicated to play a role in sepsis were
up-regulated at both the early and late time points
(Figure 3). This trend was not surprising, as it is recog-
nized that both pro- and anti- inflammatory responses are
regulated simultaneously from early stages of sepsis. [36].
Figure 2 Distribution of significant differentially expressed genes at early and late time points. Venn diagram showing the distribution of
significant differentially expressed (DE) genes at different time points.
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Our earlier findings [19,20] and current results demon-
strate that a small number of viable E. coli are present in
peritoneal lavage fluid at 18 h. Therefore, it is not surpris-
ing that a number of molecules related to immunity and
inflammation are still expressed at 18 h.
Two profiles (id 38 with 78 genes, and 14 with 18
genes) have opposing trends at early and late time points
(Figure 3). Some of the immune response related genes
with opposing trends of expression at early (up-regulated)
and late (down-regulated) time points includes, PRKCA
(protein kinase C alpha), CR2 (complement component
receptor 2), and CD3G involved in T cell co-stimulation.
PRKCA is important for FcγR mediated phagocytosis
by macrophages [37], neutrophil chemotaxis [38], and
respiratory burst in neutrophils [26]. It is interesting to
note that most of the immune response genes belonged
to cluster 49, a significant STEM cluster that represents
the trend where most of the genes were up-regulated at
2 h and their expression began to decrease by 18 h. This
pattern indicates that by 18 h the peritoneal cells exhibit
the initiation of resolution of infection.
In addition to transcriptional regulators like Rel
(NFκBIZ), whose role in inflammation and sepsis is well
established, the list of DE immune response related genes
common to all time points also has two potentially novel
transcription regulators (PLAGL2 and EBF1), not previ-
ously known to be involved in sepsis (Table 2). The
PLAGL2 gene product induces the expression of a pro-
apoptotic protein Nip-3 which causes cellular apoptosis
[39]. Compared to the early time points, the expression
of PLAGL2 was higher at 18 h. Expression of the EBF1
gene (early B cell factor 1), which decreases the differ-
entiation of mouse pro B lymphocytes [40], was up-
regulated at early time points and down-regulated at
Figure 3 Expression profiles of differentially expressed immune response genes common to early and late time points. Heat map of DE
immune response related genes common to 1, 2 h and 18 h time points and significant clusters identified by Short Time Expression Miner
(STEM) clustering software. Within each cluster, the number on top represents the profile id and the number at the bottom represents the
number of genes with similar profile patterns shown in the same colour. Sig: significant; cyt/chk: cytokine/ chemokine; trans reg: transcription
regulator; Gpcr: G-protein coupled receptor; Tr mem rec: Transmembrane receptor; Ldnr: Ligand dependent nuclear receptor; Phosp: Phosphatase.
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18 h. Expanding the transcription regulators analysis to
all DE genes with ≤ −2 or≥ 2-fold expression change, and
an immune response related function, we identified add-
itional potentially novel transcription regulators in sepsis.
In all, 20 potentially novel transcription regulators involved
in sepsis were identified (Table 2).
To increase confidence in the biological interpretation
of our microarray data, we determined the concentrations
of three cytokines and a chemokine (IL-10, IL-6, IL-1β
and MIP-1β), using a multiplex kit. The overall trends
in cytokine concentrations were consistent with those
observed with microarray except for IL-6. IL-6 protein
concentration was highest at 18 h while the gene expres-
sion was maximal at 2 h (Figure 6). However, expres-
sion was increased compared to untreated controls at
2 and 18 h.
Discussion
Sepsis is the 10th leading cause of death in the United
States [41], and the mortality rate has not changed sub-
stantially in many years, in spite of the use a wide range
of experimental therapeutics. Biological based therapies
that work well in rodent models when given before chal-
lenge have typically not worked in human sepsis patients.
This could be due to ineffectiveness of administration
of these drugs after sepsis is established or the com-
plex biological response with many partially redundant
mediators, causing inhibition of a single molecule to be
ineffective. A better understanding of the full range of
gene expression changes associated with sepsis will be
necessary to understand these issues, and this was the
purpose of the present study.
Sepsis is a result of a complex systemic dysregulation
of inflammation that results when the host is unable to
contain an infection that usually starts in a primary
organ. The inflammatory response to sepsis involves two
distinct phases which are not always mutually exclusive.
The initial acute phase is the systemic inflammatory
response, which is closely followed by the compensatory
anti-inflammatory response [17]. The dysregulation of
the immune response observed in sepsis is a combina-
tion of the local immune response at the primary site of
infection and the systemic immune response. The site of
primary infection plays a key role as it produces inflam-
matory molecules that modulate the systemic immune
response. The cellular environment of each primary
organ involved in sepsis including the immunological
functional cells (e.g., the resident macrophages) is very
specific also the microbial aetiology leading to the infec-
tion also differs considerably. Therefore it is expected
that the local immune response in sepsis varies depend-
ing on the site of primary infection and thus it is import-
ant to evaluate the organ specific immune responses.
The abdomen is the second most common primary site
of infection in sepsis. Intra-abdominal infections account
for about 20% of all sepsis cases. We used a widely
accepted [19,20,42-44] model of intraperitoneal inocula-
tion of a non-pathogenic strain of E. coli to induce sepsis.
Two early time points (1 h and 2 h) and one late time
point (18 h) were used to evaluate the changes in the
transcriptional profiles of cells in the peritoneal cavity of
the infected animals. As described in the results, the early
time points that are associated with increased bacterial
counts are expected to reflect an acute inflammatory
response. In our experience the sepsis model used in this
study is associated with very low mortality, only one out
of the ten mice in the survival study succumbed to infec-
tion (Additional file 1: Figure S1). This is expected since
Table 1 Top five functions and canonical pathways unique to 1 h, 2 h and 18 h obtained by Ingenuity pathway analysis
Top functions Top Canonical pathways
Unique to 1 h Cell cycle CD 40 signaling
Cell to cell signaling and interaction p53 signaling
Cellular assembly and organization HMGB1 signaling
DNA replication, recombination and repair Cholecystokinin/Gastrin- mediated signaling
Carbohydrate metabolism Type I diabetes mellitus signaling
Unique to 2 h Cellular development Dendritic cell maturation
Cellular function and maintenance Type I diabetes mellitus signaling
Cell cycle Role of JAK family kinase in IL-6 type cytokine signaling
Cellular growth and proliferation TREM1 signaling
Antigen presentation Altered T cell and B cell signaling in rheumatoid arthritis
Unique to 18 h Cellular movement NF-κB activation by viruses
Cell to cell signaling and interaction Glioma signaling
Cellular function and maintenance B cell receptor signaling
Cell death LPS-stimulated MAPK signaling
Antigen presentation FGF signaling
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a non-pathogenic strain of E. coli was used for infection
and most animals were able to fully clear the bacterial
load by about 21 h post infection [19]. Thus the 18 h
time point chosen in the study gives a view of the
transcriptional changes involved in initiation of the
resolution of infection. The coordinated response of
professional phagocytes (macrophages, monocytes and
neutrophils) is essential for the resolution of infection.
The bacteria were recognized by the resident peritoneal
macrophages because of their proximity to the site of in-
fection. Thus, most of the cells in the peritoneal fluid at
the early time points were macrophages (Figure 1B). The
significantly increased expression of markers associated
with macrophages was also reflected in the microarray
data at the early time points. The cytokines released by
the macrophages recruit the neutrophils from the blood
stream to the site of infection. So as the infection
progresses, the cell population in peritoneal fluid pre-
dominantly consists of neutrophils (Figure 1C). This shift
was also reflected in the microarray data at 18 h. Most of
the cells at the early time points were macrophages while
at 18 h neutrophils were the predominant cell type in the
peritoneal fluid (Figure 1B, 1C). The 18 h time point
in our mouse model is expected to correspond to the
initiation of the resolution of infection. The significant
DE genes at this time point were found to be associated
with cell death of immune cells. The apoptosis of neu-
trophils is critical for the resolution of infection as
it ends the sustained neutrophil recruitment and the
phagoctytic clearance of the apoptotic neutrophils also
re-programs the macrophages to an anti-inflammatory
phenotype [45].
We compared our results with a recent meta-analysis
of 12 studies that evaluated the blood profiles from early
Figure 4 Relative bias of functions associated with genes unique to 2 h and 18 h. The positive, negative and net bias of the gene
expression on the top functions associated with significant DE genes unique to 2 h (A) and 18 h (B) evaluated by using GoModeler workflow.
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and late stages of sepsis from human subjects [3]. In this
meta analysis, there was no clear transition between pro-
and anti-inflammatory phases at early or late stages. The
up-regulation of TNF-α, IL-1α, IL-1β, CXCL-10, SOCS3,
IL-10 at 1 and 2 h in the present study was similar to that
observed in blood profiles of sepsis patients at early
stages [11,46]. Expression of these genes peaked at 2 h
and was still up-regulated at 18 h in this study. Decreased
expression of CD69, CD36 (DE 1.78 and −5.53 respect-
ively at 18 h) and MHC II genes (H2-OB, Figure 3) in
peritoneal cell profiles is consistent with the blood pro-
files of sepsis patients at late stages of sepsis [47]. How-
ever, there are some differences in expression of some
genes at 18 h, as would be expected due to differences in
inflammatory responses in different anatomical locations
[8-10]. For example, TNF-α levels in peritoneal cells is
Figure 5 LPS stimulated MAPK pathway representing gene expression changes unique to 18 h. Canonical LPS stimulated MAPK pathway
(shown in grey) from Ingenuity pathway analysis. Significant gene expression changes unique to 18 h in this study are highlighted in red
(up-regulated) and green (down-regulated).
Table 2 Differential expression of potentially novel transcriptional regulators involved in sepsis in the mouse
peritoneal cells at different time points
Group Transcriptional regulators (DE values)
Common to 1, 2 and 18 h PLAGL2 (1.11, 2.04, 3.29), EBF1 (3.06, 3.55, -3.33)
Common to 1 and 2 h ELF1 (1.32, 1.69)
Common to 2 and 18 h AFF1 (2.55, 2.86), SKIL (3.76, 3.82)
CBFA2T3 (−2.16, -2.34), HHEX (−2.71, -2.08)
Unique to 2 h HIVEP2 (3.77), TCF7 (3.70), JARID2 (2.74), ZEB (2.11), KLF (−1.47)
LYL1 (−2.22)
Unique to 18 h EPAS1 (−5.71), BCL11A (−3.40), TAL1 (−2.72), CDKN2C (−2.47), MED7 (4.55),
SBNO2(3.28), ZBTB7B (2.43)
DE: Differential expression.
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elevated at 18 h in our study (DE 5.57), but meta-analysis
identified a decreased expression of TNF-α in blood
profiles [36,47]. The CCR2 and S100A11 genes are
up-regulated in early stages of sepsis in blood [48] but
down-regulated in the peritoneal cells in our sepsis
model. Despite a number of similarities, gene expression
in peritoneal cells differs from the patterns in blood, sug-
gesting that cell type and anatomical location as well as
species differences influence the specific characteristics
of the local inflammatory response. Nevertheless, there
were many similiarities between the early and late
responses to sepsis in humans and mice.
An important finding of this study is the identification
of 20 transcription regulators among the DE genes,
whose role in sepsis was not previously known. Some of
the transcription regulators expressed uniquely at 2 and
18 h are known to be involved in T cell regulation. Tran-
scription factor 7 (TCF-7) was up-regulated and Kruppel
like factor 10 (KLF10) was down-regulated at 2 h. TCF-7
is a critical regulator of T cell specification [49] while
KLF10 induces TGF-β1 expression. TGF-β1, an anti-
inflammatory cytokine, also regulates T cell activation
[50]. ZBTB7B, a zinc finger protein crucial for the com-
mitment of MHCII restricted thymocytes to a CD4+
lineage [51] was up-regulated at 18 h. Strawberry notch
homolgue2 (SBNO2) was also up-regulated at 18 h.
SBNO2 is induced by IL-10 and contributes to its down-
stream anti-inflammatory effects [52]. It is not clear if
the expression of T cell-related transcription regulators
indicates the presence of T cells in the peritoneal cavity
or if these transcription regulators are also expressed in
macrophages, and have not been recognized as having a
role in these cells. Lymphocytes are present in the peri-
toneal cavity (~5-10% of total cells, data not shown), and
we have previously observed expression of genes unique
to T cells (e.g., TCR), so it is possible that T cell activation
is an important event in sepsis. It is also possible that a
set of transcription regulators not previously known to
Figure 6 Peritoneal fluid cytokine concentrations and corresponding gene expression determined by microarrays. A) Cytokine
concentrations measured by bioplex (n = 5) from the peritoneal fluid of control and naive and infected mice after 1, 2 and 18 h of intraperitoneal
inoculation of 2X108 cells of E. coli ***P < 0.001, **P < 0.01, *P < 0.05. (B) Corresponding gene expression determined by microarrays in significant
differentially expressed genes.
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be expressed by macrophages are expressed and are
potentially important in regulating inflammation. Whether
changes in expression of these regulators at 18 h is due
to altered expression in macrophages or differential pat-
terns of expression in neutrophils vs. macrophages, they
are significant compared to naive mice, thus implicating
them in the host response to sepsis. It is not clear if these
transcription factors are activated by known or previously
unrecognized signaling pathways. We report here that
the best known transcription factor associated with sep-
sis, NF-κB, exhibits no alteration in transcript quantity.
However, transcriptomics does not reveal information
about activation of signaling or transcription related
molecules. Our previous study demonstrated that sepsis
substantially increases activation of NF-κB using a
transgenic reporter mouse model [20]. This serves as a
reminder that the changes in the quantity of transcripts
for transcription factors may not correspond with activa-
tion of those transcription factors. All other things being
equal, increased expression should yield increased activ-
ity, but activity needs to be measured for each transcrip-
tion factor implicated in this study. This will be done in
future studies.
Conclusions
In conclusion, the results of this study provide an evalu-
ation of the changes in the transcriptional profile of peri-
toneal cells at early and late stages of intra-abdominal
sepsis. The pattern of expression of key biomarkers for
sepsis in humans is similar to that observed in this study,
validating the findings of this study, and suggesting the
utility of this model for further studies of sepsis. We iden-
tified several novel transcription regulators which might
play an important role in immune response to sepsis and
could be useful diagnostic markers or therapeutic targets.
Future experimental studies are needed to validate and de-
termine the role of these transcription regulators in sepsis.
Methods
Mice, treatments, and procedure
We used 12–16 weeks old female C57Bl/6 × C3H F1
mice obtained through the National Cancer Institute’s
Animal Program for all experiments. The mice were
acclimatized for at least two weeks in filter top shoebox
cages (5/cage) in a temperature (70-78°F) and humidity
(40-60%) controlled environment in accordance with
NIH and Louisiana State University regulations. The care
and use of mice in this study were approved by the LSU
Health Sciences Center Institutional animal care and use
committee. Sentinel mice periodically housed in the same
room as experimental animals were negative for infec-
tious agents during the period of this study.
We divided mice into control and E. coli treated
groups. The treated group received 2 × 108 cfu of a non-
pathogenic strain of E. coli harvested in mid-log phase,
suspended in a phosphate buffered saline (PBS) solution,
intraperitoneally as described [19]. The non-pathogenic
isolate of E. coli used in the study was isolated from the
colon of one of the mice in our specific pathogen free
colony. The control mice were injected with an equal
volume of PBS intraperitoneally. We euthanized mice
1 h, 2 h and 18 h post E. coli administration by inhala-
tion of isoflurane and performed peritoneal lavage as
described [53] A group of mice which received PBS was
harvested at 2 h served as a common control group for
1 h and 2 h. The use of a common control group har-
vested at 2 h for both the early time points is unlikely
to affect the interpretation of the 1 h results as the only
difference expected between these two control groups
would be related to circadian changes in expression of
some genes. It must be considered that these differences
would be quantitatively small in almost all cases after
only 1 h of difference as extrapolated from results of
Akhtar and colleagues, who evaluated gene expression
every 4 h [54]. Peritoneal lavage fluid was also
obtained from a second group of mice receiving PBS
intraperitoneally after 18 h, this served as a control
group for the 18 h treatment. A group of 10 mice
were used for survival studies. These mice were inoculated
with 2 × 108 cfu of a non-pathogenic strain of E. coli
intraperitoneally.
Bacterial and cell counts from peritoneal fluid
An aliquot of peritoneal fluid at each time point was
serially diluted in Luria Bertani agar to determine the
bacterial counts after overnight incubation at 37°C.
We centrifuged the remaining peritoneal fluid, and used
the pellets for cell counts and RNA extraction, and the
supernatant for cytokine/chemokine analysis. The total
cell counts were done using Coulter Z1 particle counter
(Hialeah, FL). Differential cell counts were determined
by cytospin preparations. Following cytospin, the cells
were stained with Wright-Giemsa stain and observed
under 600 × magnification under an oil immersion lens
to differentiate between the different cells types. In order
to assess the phagocytosis of bacteria by the macro-
phages and neutrophils we used a criteria where the cells
with three or more bacteria associated were referred
to as cells with E. coli, and cells with less than three bac-
teria were referred to as cells without E. coli as described
previously [19].
A criteria of 3 or more bacteria was used to account
for the possibility that some of the bacteria that appeared
to be intracellular might actually be on the cell surface.
Although the method used here does not provide a pre-
cise quantitation of the phagocytosis but it gives a good
estimation of the temporal changes in phagocytosis by
the different cells types.
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Cytokine and chemokine assays
Concentrations of select cytokines and chemokines in
peritoneal fluid were determined by Bio-Rad (Hercules,
CA) multiplexed bead array kits following manufacturer’s
protocols and with a BioPlex analyzer (Bio-Rad).
RNA isolation, microarrays and functional analysis
We extracted RNA from the peritoneal cells of E. coli
challenged and control mice after taking a small sample
for cytospin analysis. The RNA was isolated using the
TRIZol protocol (Invitrogen, Stockholm, Sweden). An
Agilent Bioanalyzer was used to assess the quality of the
RNA samples. Samples were selected for analysis in
part by the 28S/18S ratio with a value of 1.4 or greater as
the criterion for use. The microarray analysis was done
as described previously [53] except that we used Mouse
430 2.0 GeneChipW microarray. The primary labeled
cRNA was synthized from 7.5 μg total RNA using the
Affymetrix one cycle labeling kit. We performed
hybridization, staining, washing, and scanning of the
Mouse 430 2.0 GeneChipW microarray according to Affy-
metrix protocols. Using GeneSifter (Geospiza, Perkin
Elmer Inc) we normalized raw data by robust multichip
algorithm (RMA). Box-whisker plots of expression values
before and after normalization show that the RMA
adjusted to the same median value with similar 1st and
3rd quartiles and similar second and 98th percentiles.
The microarray data was submitted to NCBI GEO with
accession number GSE34114.
For statistical analysis, a pooled within treatment error
was computed and this was used to perform t tests for
comparison at each time point i.e. at each time point the
control is compared to the treatment group. To account
for the false positives, the P values were adjusted for mul-
tiple comparisons using a 5% false discovery rate. We
used genes that were significantly up- or down-regulated
at different time points for further analysis. Differen-
tial expression for each gene represents the difference
between the expression values of E. coli treated and the
respective control.
We analyzed DE genes common to all time points by
hierarchical clustering (average linkage clustering metrics
and Pearson correlation for the distance) and generated
heat maps with TIGR MeV (Multi Experiment Viewer)
V4.3.01 software [55]. We determined statistically signifi-
cant clusters in our time course experiment by using the
software tool Short Time series Expression Miner (STEM
version v1.3.6) [56]. To generate a common baseline for
the temporal assessment with STEM, we normalized the
data by adding a “0” for each gene.
We identified significant functions, canonical path-
ways and networks associated with the DE genes using
Ingenuity pathway analysis (Ingenuity systems, Redwood
City, California, USA). The net effect (positive or
negative bias) of gene expression changes specific to 2
and 18 h on the top 5 functions identified by IPA was
evaluated using GoModeler [35].
Additional file
Additional file 1: Figure S1. Survival studies in the mouse model of
sepsis. A group of 10 mice were inoculated with of 2 × 108 cells of E. coli
intraperitoneally and observed for survival.
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